Información del artículo
Resumen
Introducción
El objetivo del presente artículo es presentar las recomendaciones basadas en la evidencia que surgieron como respuesta a una serie de preguntas clínicas con respecto al episodio depresivo y al trastorno depresivo recurrente, haciendo hincapié en los aspectos generales del tratamiento de la depresión resistente y la depresión con psicosis, el tratamiento con terapia ocupacional y el hospital día, con el fin de brindar parámetros de atención en salud basados en la mejor y más actualizada evidencia disponible para lograr los estándares mínimos de calidad en el abordaje de adultos con dichos diagnósticos.
MétodoSe elaboró una guía de práctica clínica bajo los lineamientos de la Guía Metodológica del Ministerio de la Protección Social. Se adaptaron las recomendaciones de las guías NICE90 y CANMAT para las preguntas que estas guías contestaban y se desarrollaron de novo para las preguntas no encontradas.
ResultadosSe presentan las recomendaciones 23-25 correspondientes al manejo de la depresión.
Palabras clave:
Guía de práctica clínica
trastorno depresivo
tratamiento de la depresión
depresión resistente
terapia ocupacional
hospital de día
Abstract
Introduction
This article presents recommendations based on the evidence gathered to answer a series of clinical questions concerning the depressive episode and the recurrent depressive disorder. Emphasis was given to general treatment issues of resistant depression and psychotic depression, occupational therapy and day hospital treatment so as to grant diagnosed adult patients the health care parameters based on the best and more updated evidence available and achieve minimum quality standards.
MethodologyA practical clinical guide was elaborated according to standards of the Methodological Guide of the Ministry of Social Protection. Recommendation from NICE90 and CANMAT guides were adopted and updated so as to answer the questions posed while de novo questions were developed.
ResultsRecommendations 23-25 corresponding to the management of depression are presented.
Key words:
Practice guideline
depressive disorder
depressive disorder treatment-resistant
occupational therapy
hospital day
El Texto completo está disponible en PDF
Referencias citadas
[1]
American Psychiatric Association (APA).
Manual diagnóstico y estadístico de los trastornos mentales. DSM-IV. Versión en español, Masson, (2002),
[2]
C Gómez-Restrepo, M Uribe Restrepo, M Alzate García, et al.
Trastornos afectivos: Trastornos depresivos.
Psiquiatría Clínica. Diagnóstico y tratamiento en niños, adolescentes y adultos, 3ª edición,
[3]
World Psychiatric Association (WPA).
International Committee for prevention & treatment of depression. Educational Program on Depressive Disorders, NCM Publishers Inc, (1997),
[4]
World Health Organization (WHO).
The global burden of disease: 2004 update, WHO Press, (2008),
[5]
J Posada Villa, S Aguilar, C Magaña, et al.
Prevalencia de los trastornos mentales y uso de servicios: resultados preliminares del estudio nacional de salud mental: Colombia 2003.
Rev Col Psiquiatría, 33 (2004), pp. 241-262
[6]
República de Colombia.
Ministerio de la Protección Social (MPS). Estudio Nacional de Salud Mental, MPS, (2003),
[7]
MH Trivedi, AJ Rush, BN Gaynes, et al.
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.
Neuropsychopharmacology, 32 (2007), pp. 2479-2489
[8]
SV Parikh, ZV Segal, S Grigoriadis, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.
J Affect Disord, 117 (2009), pp. S15-S25
[9]
DL Dunner, AJ Rush, JM Russell, et al.
Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression.
J Clin Psychiatry, 67 (2006), pp. 688-695
[10]
J Johnson, E Horwath, MM Weissman.
The validity of major depression with psychotic features based on a community study.
Arch Gen Psychiatry, 48 (1991), pp. 1075-1081
[11]
L Forty, L Jones, I Jones, et al.
Is depression severity the sole cause of psychotic symptoms during an episode of unipolar major depression? A study both between and within subjects.
J Affect Disord, 114 (2009), pp. 103-109
[12]
J Wijkstra, H Burger, WW van den Broek, et al.
Long-term response to successful acute pharmacological treatment of psychotic depression.
J Affect Disord, 114 (2009), pp. 103-109
[Anton and Burch, 1990]
RF Anton Jr, EA Burch Jr.
Amoxapine versus amitriptilyne combined with perphenazine in the treatment of psychotic depression.
Am J Psychiatry, 147 (1990), pp. 1203-1208
[Baldomero et al., 2005]
EB Baldomero, JG Ubago, CL Cercós, et al.
Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study.
Depress Anxiety, 22 (2005), pp. 68-76
[Bares et al., 2009]
M Bares, M Kopecek, T Novak, et al.
Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
J Affect Disord, 118 (2009), pp. 94-100
[Bellini et al., 1994]
L Bellini, M Gasperini, F Gatti, et al.
A double-blind study with fluvoxamina versus desipramine combined with placebo or haloperidol in delusional depression.
Crit Issues, 9 (1994), pp. 32-36
[Dannon et al., 2006]
PN Dannon, K Lowengrub, Y Gonopolski, et al.
Current and emerging somatic treatment strategies in psychotic major depression.
Expert Rev Neurother, 6 (2006), pp. 73-80
[Dunner et al., 2006]
DL Dunner, AJ Rush, JM Russell, et al.
Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression.
J Clin Psychiatry, 67 (2006), pp. 688-695
[Farahani and Correll, 2012]
A Farahani, CU Correll.
Are Antipsychotics or antidepressants needed for psychotic depression? a systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment.
J Clin Psychiatry, 73 (2012), pp. 486-496
[Fava et al., 2003]
M Fava, AJ Rush, MH Trivedi, et al.
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.
Psychiatr Clin North Am, 26 (2003), pp. 457-494
[Forty et al., 2009]
L Forty, L Jones, I Jones, et al.
Is depression severity the sole cause of psychotic symptoms during an episode of unipolar major depression? A study both between and within subjects.
J Affect Disord, 114 (2009), pp. 103-109
[George and Post, 2011]
MS George, RM Post.
Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression.
Am J Psychiatry, 168 (2011), pp. 356-364
[Hand et al., 2011]
C Hand, M Law, MA McColl.
Occupational therapy interventions for chronic diseases: a scoping review.
Am J Occup Ther, 65 (2011), pp. 428-436
[Hees et al., 2010]
HL Hees, MW Koeter, G de Vries, et al.
Effectiveness of adjuvant occupational therapy in employees with depression: design of a randomized controlled trial.
BMC Public Health, 10 (2010), pp. 558
[Johnson et al., 1991]
J Johnson, E Horwath, MM Weissman.
The validity of major depression with psychotic features based on a community study.
Arch Gen Psychiatry, 48 (1991), pp. 1075-1081
[Kennedy et al., 2009]
SH Kennedy, R Milev, P Giacobbe, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies.
J Affect Disord, 117 (2009), pp. S44-S53
[Komossa et al., 2012]
K Komossa, AM Depping, A Gaudchau, et al.
Second-generation antipsychotics for major depressive disorder and dysthymia.
Cochrane Database Syst Rev, (2012),
[Lam et al., 2008]
RW Lam, P Chan, M Wilkins-Ho, et al.
Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis.
Can J Psychiatry, 53 (2008), pp. 621-631
[Lam et al., 2009]
RW Lam, SH Kennedy, S Grigoriadis, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.
J Affect Disord, 117 (2009), pp. S26-S43
[Marshall et al., 2001]
M Marshall, R Crowther, A Almaraz-Serrano, et al.
Systematic reviews of the effectiveness of dy are for people with severe mental disorders: (I) Acute day hospital versus admission; (2) Vocational rehabilitation; (3) Day hospital versus outpatient care.
Health Tech Assess, 5 (2001), pp. 1-75
[Meyers et al., 2009]
BS Meyers, AJ Flint, AJ Rothschild, et al.
A Double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression the study of pharmacotherapy of psychotic depression (STOP-PD).
Arch Gen Psychiatry, 66 (2009), pp. 838-847
[Mulsant et al., 2001]
BH Mulsant, RA Sweet, J Rosen, et al.
A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.
J Clin Psychiatry, 62 (2001), pp. 597-604
[Murray et al., 2010]
G Murray, EE Michalak, A Axler, et al.
Relief of chronic or resistant depression (Re-ChORD): a pragmatic, randomized, open-treatment trial of an integrative program intervention for chronic depression.
J Affect Disord, 123 (2010), pp. 243-248
[National Collaborating Centre for Mental Health, 2010]
National Collaborating Centre for Mental Health.
Depression. The NICE Guideline on the treatment and management of depression in adults (Updated Edition) (National Clinical Practice Guideline 90). National Institute for Health and Clinical Excellence (NICE, The British Psychological Society and The Royal College of Psychiatrists, (2010),
[Parikh et al., 2009]
SV Parikh, ZV Segal, S Grigoriadis, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.
J Affect Disord, 117 (2009), pp. S15-S25
[Petrides et al., 2001]
G Petrides, M Fink, MM Husain, et al.
ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE.
J Ect, 17 (2001), pp. 244-253
[Rothschild, 2003]
AJ Rothschild.
Challenges in the treatment of depression with psychotic features.
Biol Psychiatry, 53 (2003), pp. 680-690
[Rush et al., 2003]
AJ Rush, M Trivedi, M Fava.
Depression, IV: STAR*D treatment trial for depression.
Am J Psychiatry, 160 (2003), pp. 237
[Schene et al., 2007]
AH Schene, MW Koeter, MJ Kikkert, et al.
Adjuvant occupational therapy for work-related major depression works: randomized trial including economic evaluation.
Psychol Med, 37 (2007), pp. 351-362
[Smith et al., 2008]
E Smith, AJ Rothschilda, M Heob, et al.
Weight gain during olanzapine treatment for psychotic depression: effects of dose and age.
Int Clin Psychopharmacol, 23 (2008), pp. 130-137
[Spiker et al., 1985]
DG Spiker, JC Weiss, RS Dealy, et al.
The Pharmacological treatment of delusional depression.
Am J Psychiatry, 142 (1985), pp. 430-436
[Trivedi et al., 2007]
MH Trivedi, AJ Rush, BN Gaynes, et al.
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.
Neuropsychopharmacology, 32 (2007), pp. 2479-2480
[Trivedi et al., 2011]
RB Trivedi, JA Nieuwsma, JW Williams Jr.
Examination of the utility of psychotherapy for patients with treatment resistant depression: a systematic review.
J Gen Intern Med, 26 (2011), pp. 643-650
[Wijkstra et al., 2009]
J Wijkstra, H Burger, WW van den Broek, et al.
Long-term response to successful acute pharmacological treatment of psychotic depression.
J Affect Disord, 114 (2009), pp. 103-109
[Wijkstra et al., 2010]
J Wijkstra, H Burger, WW van den Broek, et al.
Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine.
Acta Psychiatr Scand, 121 (2010), pp. 190-200
[Wijkstra et al., 2005]
J Wijkstra, J Lijmer, F Balk, et al.
Pharmacological treatment for psychotic depression.
Cochrane Database Syst Rev, (2005),
[Wijkstra et al., 2006]
J Wijkstra, J Lijmer, FJ Balk, et al.
Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis.
Br J Psychiatry, 188 (2006), pp. 410-415
[Zanardi et al., 1996]
R Zanardi, L Franchini, M Gasperini, et al.
Duoble-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression.
Am J Psychiatry, 153 (1996), pp. 1631-1633
[Zanardi et al., 2000]
R Zanardi, L Franchini, A Serreti, et al.
Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study.
J Clin Psychiatry, 61 (2000), pp. 26-29
La Guía de Atención Integral completa fue desarrollada por el Grupo que aparece en el anexo de este artículo. Este artículo-resumen fue redactado por los integrantes del grupo que se mencionan bajo el título. Financiación: El desarrollo de la Guía de Atención Integral fue financiado por el Ministerio de Salud y Protección Social y por el Departamento Administrativo de Ciencia, Tecnología e Innovación (Colciencias), mediante Contrato 126 de 2010 suscrito con la Pontificia Universidad Javeriana. Convocatoria 500 de 2009 de Colciencias (Conformación de un banco de proyectos para el desarrollo de Guías de Atención Integral (GAI) Basadas en Evidencia), fue elegido por el Consejo del Programa Nacional de Ciencia y Tecnología de la Salud, el proyecto fue liderado por la Pontificia Universidad Javeriana, en alianza con la Universidad de Antioquia y la Universidad Nacional de Colombia (Alianza CINETS).
Conflictos de interés: Los autores manifiestan que no tienen conflictos de interés en este artículo.
Copyright © 2012. Asociación Colombiana de Psiquiatría
Publique en
Revista Colombiana de Psiquiatría
Herramientas
Artículos
recomendados
recomendados
Rev Colomb Psiquiatr. 2025;54:398-404
Rev Colomb Psiquiatr. 2024;53:448-57
Rev Colomb Psiquiatr. 2024;53:210-6
Revista Colombiana de Psiquiatría se adhiere a los principios y procedimientos dictados por el Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.
Open access
Esta obra está licenciada por una Licencia Creative Commons Attribution 4.0 International License.
